CARDIAC I
CARDIAC II
CARDIAC III
CARDIAC IV
CARDIAC V
100

BLOCKS ENZYME RESPONSIBLE FOR CONVERTING ANGIOTENSIN ONE TO TWO 

CAPTOPRIL 

100

POTASSIUM SPARING DIURETEIC 

SPIRONOLACTONE 

100

NORMAL POTASSIUM LEVEL 

3.5 - 5.0 

100

POTASSIUM LOSING DIURETIC 

FUROSEMIDE 

100

ABREVIATION FOR LIVER ENZYMES 

ALT/AST

200

NAME OF CLINICAL SYMPTOM WHEN BECOME DIZZY UPON RISING 

ORHTOSTATIC HYPOTENSION 

200

HEALTH TEACHING MAY INCLUDE TAKING THIS MEDICATION PRIOR TO NITROGLYCERIN 

ACETAMINOPHEN 

200

POPULAR HERB THAT INTERACTS WITH VARIOUS MEDICATIONS 

ST. JOHN WART 

200

PRLONGED SUN EXPOSURE SHOULD BE AVOIDED WHEN PRESCRIBED THIS MEDICATION 

HYDROCHLOROTHIAZIDE 

200

THE NURSE IS TO ADMINISTER NITROGLYCERIN.  CLIENT VERBALIZES "DIZZINESS" THE NURSE SHOULD?  

NOT ADMINISTER NITROGLYCERIN UNTIL BP IS ASSESSED FOR HYPOTENSION 

300

SIGNIFICANT ADVERSE EFFECT OF ACE INHIBITORS 

ANGIOEDEMA 

300

CLIENT EDUCATION FOR ATORVASTATIN SHOULD INCLUDE AVOIDING THIS BEVERAGE WITH BREAKFAST MEAL 

GRAPEFRUIT JUICE 

300

LABORATROY RESULTS OFTEN REVIEWED PRIOR TO ADMINISTERING LISINOPRIL ? 

CHEMISTRY PANEL (INCLUDES ELECTROLYTES AND BUN WHICH REQUIRE REVIEW AND POSSIBILITY OF HOLDING MEDICATION) 

300

HEALTH TEACHING FOR THIS MEDICATION INCLUDES STORING IN DRY, COOL DARK ENVIRONMENT 

NITROGLYCERIN 

300

THIS MEDICATION IS BENEFICIAL IN TREATMENT OF HYPERTENSION IS AFRICAN AMERICAN POPULATION 

AMLODIPINE 

400

BELONGS TO DRUG CLASS ANGIOTENSION II RECEPTOR BLOCKER (ARB)

LOSARTAN 

400

CLIENT COMPLAINTS OF NAUSEA/VOMITING AND K(+) 3 MAY BE EXPERIENCEING THIS? 

LANOXIN TOXICITY 

400

TIME FRAME TO DRAW A LANOXIN LEVEL 

6 - 8 HOURS AFTER LAST DOSE 

400

THIS ARB MAY BE INEFFECTIVE IN BP MANAGEMENT FOR THE AFRICAN AMERICAN CLIENT 

LOSARTAN 

400

RESISTANCE LEFT VENTRICLE MUST OVERCOME TO CIRCULATE BLOOD 

AFTERLOAD 

500

THIAZIDE DIURETIC 

HYDROCHLOROTHIAZIDE 

500

TIME LIMIT TO ADMINISTER FUROSEMIDE IV 

1 - 2 MINUTES 

500

THIS INGREDIENT IS HIGH IN POTASIUM AND SHOULD BE AVOIDED WITH CHF 

SALT SUBSTITUES SUCH AS MRS. DASH 

500

AN ADVERSE EFFECT OF THIS MEDICATION IS MYOSITIS 

ATORVOSTATIN 

500

THERAPEUTIC DIGOXIN LEVEL 

0.5 - 2 mg/mL